Dr. reddy's laboratories announces the launch of lenalidomide capsules in the u.s. with two of six strengths eligible for first-to-market, 180-day exclusivity

Hyderabad, india & princeton, n.j.--(business wire)---- $rdy #affordablemedicines--dr. reddy's laboratories ltd. today announced the launch, in the u.s. market, of lenalidomide capsules.

RDY Ratings Summary

RDY Quant Ranking